MPAM
FLXN

Monarch Partners Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Monarch Partners Asset Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-75,935
Closed -$680K – 184
2021
Q1 		$680K Sell
75,935
-2,235
-3% -$25.6K 0.1% 145
2020
Q4 		$902K Sell
78,170
-8,460
-10% -$98.3K 0.16% 144
2020
Q3 		$902K Buy
86,630
+27,920
+48% +$342K 0.2% 126
2020
Q2 		$772K Buy
58,710
+33,815
+136% +$351K 0.19% 111
2020
Q1 		$196K Buy
+24,895
New +$375K 0.07% 152
2018
Q4 		– Sell
-24,050
Closed -$450K – 223
2018
Q3 		$450K Buy
24,050
+3,260
+16% +$74.9K 0.04% 181
2018
Q2 		$537K Sell
20,790
-310
-1% -$8.04K 0.05% 172
2018
Q1 		$473K Buy
21,100
+7,560
+56% +$185K 0.04% 175
2017
Q4 		$339K Sell
13,540
-6,250
-32% -$153K 0.03% 174
2017
Q3 		$479K Buy
19,790
+480
+2% +$11.3K 0.05% 156
2017
Q2 		$390K Buy
19,310
+8,930
+86% +$186K 0.04% 159
2017
Q1 		$279K Buy
+10,380
New +$212K 0.03% 168

Other funds holding FLXN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return